Report ID :10151863 |
Published Date : 21 Oct 2022 |
Report Format : |
Delivery Timeline :48-72 Business Hours
"According to a new report by Kenneth Research, by 2022, the global vaccine contract manufacturing market is expected to reach USD 5 billion, and it will grow at a compound annual growth rate of ~10% during the forecast period 2022-2030. Due to the increasing demand for vaccine development by the private sector and governments of industrialized and developing countries, the market is expected to witness significant growth in the next few years. Vaccine contract services provide your customers with cost-saving benefits. They also help to save time in the operation and management of research and production facilities. These advantages associated with contract manufacturing organizations (CMO) are expected to benefit start-ups, start-ups, and small businesses that lack sufficient facilities and resources for vaccine development.
They are expected to have a negative impact on the market. Contract services are regarded by vaccine manufacturers as strategic competitive weapons; because they help overcome the above-mentioned problems. Some international health care organizations are committed to estimating and forecasting the amount of assets and financial needs needed to implement the immunization program. Some factors considered in this estimate include the number of vaccines, estimated delivery time, product type, and vial size. The participation of the International Health Organization in the vaccination program is expected to have a positive impact on the growth of contract manufacturers.
Vaccine Contract Manufacturing Market Report Highlights:
Contract services for the development of live vaccines account for the majority of the market by vaccine type.
This can be attributed to the fact that these vaccines can provide lifelong immunity with just one or two doses.
DNA vaccines are the fastest growing segment by type, and several types have been tested in humans.
Based on workflow, post-processing dominates the market, mainly due to the need for mature and reliable biotechnology tools to recycle products. Various research projects in this field also help to advance the follow-up work process. From the perspective of applications, human vaccine development contract services account for the largest proportion because they are widely used to develop vaccines against influenza and other diseases. Lonza; IDT Biologika Co., Ltd.; FUJIFILM Diosynth Biotechnologies USA, Inc.; and Merck KGaA are vaccines Some major players in the development and provision of services.
Vaccine contract manufacturing market segmentation:
Kenneth Research has segmented the global vaccine contract manufacturing market based on vaccine type, workflow, application and region: Vaccine outlook for vaccine contract manufacturing type (revenue, million dollars, 2022-2030) Attenuated vaccines Inactivated Subunit Vaccine Toxoid Vaccine DNA Vaccine Contract Manufacturing Workflow Outlook (Revenue, USD million, 2022-2030 Complete operation analysis and QC research Package upstream mammalian expression system, bacterial expression system, yeast expression system, baculovirus/insect Expression system. "
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
